hydroxyzine pamoate

Generic: hydroxyzine pamoate

Labeler: pd-rx pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name hydroxyzine pamoate
Generic Name hydroxyzine pamoate
Labeler pd-rx pharmaceuticals, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

hydroxyzine pamoate 25 mg/1

Manufacturer
PD-Rx Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 43063-172
Product ID 43063-172_42dede37-3c6b-c199-e063-6294a90a635c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA087479
Listing Expiration 2026-12-31
Marketing Start 1981-12-14

Pharmacologic Class

Classes
antihistamine [epc] histamine receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 43063172
Hyphenated Format 43063-172

Supplemental Identifiers

RxCUI
995253
UNII
M20215MUFR

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name hydroxyzine pamoate (source: ndc)
Generic Name hydroxyzine pamoate (source: ndc)
Application Number ANDA087479 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
source: ndc
Packaging
  • 4 CAPSULE in 1 BOTTLE, PLASTIC (43063-172-04)
source: ndc

Packages (1)

Ingredients (1)

hydroxyzine pamoate (25 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "42dede37-3c6b-c199-e063-6294a90a635c", "openfda": {"unii": ["M20215MUFR"], "rxcui": ["995253"], "spl_set_id": ["53153595-41b9-4b2d-8b7d-0ffd29fdd1d8"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "4 CAPSULE in 1 BOTTLE, PLASTIC (43063-172-04)", "package_ndc": "43063-172-04", "marketing_start_date": "20140628"}], "brand_name": "hydroxyzine pamoate", "product_id": "43063-172_42dede37-3c6b-c199-e063-6294a90a635c", "dosage_form": "CAPSULE", "pharm_class": ["Antihistamine [EPC]", "Histamine Receptor Antagonists [MoA]"], "product_ndc": "43063-172", "generic_name": "hydroxyzine pamoate", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "hydroxyzine pamoate", "active_ingredients": [{"name": "HYDROXYZINE PAMOATE", "strength": "25 mg/1"}], "application_number": "ANDA087479", "marketing_category": "ANDA", "marketing_start_date": "19811214", "listing_expiration_date": "20261231"}